# Paroxysmal Kinesigenic Dyskinesia (PKD)

Paroxysmal kinesigenic dyskinesia — PKD — is the most common and most recognizable of the PRRT2-related conditions. Its name describes it precisely: *paroxysmal* (it happens in sudden episodes), *kinesigenic* (movement triggers it), and *dyskinesia* (abnormal, involuntary movement).

## What an episode is like

A PKD episode is triggered by a **sudden voluntary movement** — standing up quickly, breaking into a walk, being startled. In the moment right after that trigger, the body produces movement the person did not intend: muscles may twist and stiffen (dystonia), or jerk and writhe (chorea). It can affect the limbs, and sometimes the face.

Three features make PKD distinctive:

* **The episodes are brief.** Most last only seconds, and rarely more than a minute or so.
* **Consciousness is fully preserved.** The person is completely aware throughout — PKD is not a seizure, even though it can be mistaken for one.
* **A warning often comes first.** Many people feel a brief sensation — a tightening or crawling feeling in the affected limb — in the instant before an episode.

Episodes can happen many times a day, especially during periods when symptoms are active.

## Who develops PKD, and when

PKD usually begins in **childhood or adolescence**. It is rare in the general population — estimated at roughly 1 in 150,000 — and PRRT2 is its leading genetic cause. It can run in families or appear without a known family history.

## Why movement is the trigger

The "kinesigenic" trigger is the signature of the condition. A sudden movement sends a surge of activity through the motor circuits of the brain — and in a nervous system where PRRT2 is in short supply, those circuits are already over-excitable. The surge tips them briefly into a burst of abnormal output. (The mechanism is explained in [The Sodium Channel Connection](/prrt2-gene-overview/sodium-channel-connection.md).)

## Treatment and outlook

PKD is, in one important respect, a hopeful diagnosis: it is **notably responsive to treatment**. Low doses of sodium-channel-blocking medication — carbamazepine in particular — are well established as highly effective, often reducing or stopping episodes substantially. Many people also find that PKD lessens with age. Treatment is covered in [Treatments & Management](/treatments-and-management/how-treatment-works.md).

{% hint style="success" %}
**🧭 PRRT2.org Perspective**

*PRRT2.org's own perspective — our synthesis and lived experience, offered alongside the established science, not as established medical fact.*

PKD is one of the most treatable conditions in neurology — and yet people can spend years undiagnosed. The brief, dramatic, movement-triggered episodes are frequently mistaken for epilepsy, or dismissed as a tic, a habit, or something psychological.

In our experience that gap is the real problem: not that PKD is hard to treat, but that it is hard to *recognize*. The features above — the movement trigger, the brevity, the preserved awareness, the warning sensation — are a recognizable signature once someone knows to look for it.

PRRT2.org's view is that knowing this pattern, and bringing it clearly to a clinician, is one of the most useful things a patient or family can do. A condition this responsive to treatment should not cost anyone years of their life to a missed diagnosis.
{% endhint %}

## Sources

The established science on this page is drawn from:

* [MedlinePlus Genetics — PRRT2 gene](https://medlineplus.gov/genetics/gene/prrt2/) — U.S. National Library of Medicine, NIH
* [GeneReviews — Familial Paroxysmal Kinesigenic Dyskinesia](https://www.ncbi.nlm.nih.gov/books/NBK1460/) — University of Washington / NCBI
* [OMIM — Entry 614386](https://omim.org/entry/614386) — Johns Hopkins University

For the complete set of authoritative references, see [Official Resources](/resources/official-resources.md).

## Continue reading

* [Benign Familial Infantile Seizures (BFIS)](/associated-conditions/bfis.md) — the infantile-epilepsy part of the spectrum
* [How to Get Tested](/diagnosis-and-genetic-testing/how-to-get-tested.md) — confirming a PRRT2 diagnosis
* [How Treatment Works for PRRT2](/treatments-and-management/how-treatment-works.md) — why sodium-channel medications help


---

# Agent Instructions: Querying This Documentation

If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter:

```
GET https://www.prrt2.org/associated-conditions/pkd.md?ask=<question>
```

The question should be specific, self-contained, and written in natural language.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.